Calamos Advisors
ELGX

Calamos Advisors’s Endologix Inc ELGX Stock Holding History

Calamos Advisors’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,921
Closed -$448K – 729
2015
Q2 		$448K Hold
2,921
– – ﹤0.01% 596
2015
Q1 		$499K Sell
2,921
-2,723
-48% -$413K ﹤0.01% 594
2014
Q4 		$863K Hold
5,644
– – 0.01% 548
2014
Q3 		$598K Buy
5,644
+1,381
+32% +$192K ﹤0.01% 564
2014
Q2 		$648K Hold
4,263
– – ﹤0.01% 575
2014
Q1 		$549K Buy
4,263
+60
+1% +$9.33K ﹤0.01% 581
2013
Q4 		$733K Buy
4,203
+1,113
+36% +$191K ﹤0.01% 543
2013
Q3 		$498K Buy
+3,090
New +$487K ﹤0.01% 555

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Calamos Advisors's ELGX Position: Q3 2015 in Review

Calamos Advisors sold out of Endologix Inc (ELGX) in Q3 2015, closing a stake of 2,921 shares — an estimated $448K sold.

Calamos Advisors first reported a position in ELGX in Q3 2013 and held it in 8 quarters. The position peaked at $863K in Q4 2014. 125 funds tracked by Wall St. Rank hold ELGX as of Q3 2015.

  • Calamos Advisors reported no remaining Endologix Inc position as of Q3 2015 after selling out during the quarter.
  • Calamos Advisors sold 2,921 Endologix Inc shares in Q3 2015, an estimated $448K.
  • Calamos Advisors first reported a position in Endologix Inc in Q3 2013 and held it in 8 quarters.
  • Calamos Advisors's Endologix Inc position peaked at $863K in Q4 2014.
  • 125 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2015.

Based on Calamos Advisors's 13F filing for Q3 2015, filed 10 Nov 2015.